(Q39711731)

English

Serum levels of advanced glycation end products (AGEs) are inversely associated with the number and migratory activity of circulating endothelial progenitor cells in apparently healthy subjects

scientific article published on 18 February 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 September 2017

Serum levels of advanced glycation end products (AGEs) are inversely associated with the number and migratory activity of circulating endothelial progenitor cells in apparently healthy subjects (English)

1 reference

Europe PubMed Central

14 September 2017

0 references

author name string

So Ueda

1

1 reference

Europe PubMed Central

14 September 2017

Sho-ichi Yamagishi

2

1 reference

Europe PubMed Central

14 September 2017

Takanori Matsui

3

1 reference

Europe PubMed Central

14 September 2017

Yoshihiro Noda

4

1 reference

Europe PubMed Central

14 September 2017

Shin-ichiro Ueda

5

1 reference

Europe PubMed Central

14 September 2017

Yuko Jinnouchi

6

1 reference

Europe PubMed Central

14 September 2017

Ken-ichiro Sasaki

7

1 reference

Europe PubMed Central

14 September 2017

Masayoshi Takeuchi

8

1 reference

Europe PubMed Central

14 September 2017

Tsutomu Imaizumi

9

1 reference

Europe PubMed Central

14 September 2017

publication date

18 February 2011

1 reference

Europe PubMed Central

14 September 2017

Cardiovascular Therapeutics

1 reference

Europe PubMed Central

14 September 2017

30

1 reference

Europe PubMed Central

14 September 2017

4

1 reference

Europe PubMed Central

14 September 2017

249-254

1 reference

Europe PubMed Central

14 September 2017

Endothelial progenitor cells in cardiovascular disorders

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00264.X

21 January 2018

Clinical and therapeutical implications of EPC biology in atherosclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00264.X

21 January 2018

Role of oxidative stress in the development of vascular injury and its therapeutic intervention by nifedipine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00264.X

21 January 2018

Roles of oxidative stress and redox regulation in atherosclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00264.X

21 January 2018

Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00264.X

21 January 2018

Circulating endothelial progenitor cells, vascular function, and cardiovascular risk

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00264.X

21 January 2018

Impaired progenitor cell activity in age-related endothelial dysfunction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00264.X

21 January 2018

Advanced protein glycosylation in diabetes and aging

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00264.X

21 January 2018

Advanced glycation end products and receptor-oxidative stress system in diabetic vascular complications

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00264.X

21 January 2018

Atherosclerosis and diabetes: the RAGE connection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00264.X

21 January 2018

Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00264.X

21 January 2018

Advanced glycation end-products in senile diabetic and non-diabetic patients with cardiovascular complications

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00264.X

21 January 2018

High serum levels of advanced glycation end products predict increased coronary heart disease mortality in nondiabetic women but not in nondiabetic men: a population-based 18-year follow-up study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00264.X

21 January 2018

Increased serum levels of advanced glycation endproducts predict total, cardiovascular and coronary mortality in women with type 2 diabetes: a population-based 18 year follow-up study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00264.X

21 January 2018

Increased serum levels of methylglyoxal-derived hydroimidazolone-AGE are associated with increased cardiovascular disease mortality in nondiabetic women

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00264.X

21 January 2018

Advanced glycation end products and endothelial dysfunction in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00264.X

21 January 2018

Positive association between serum levels of advanced glycation end products and the soluble form of receptor for advanced glycation end products in nondiabetic subjects.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00264.X

21 January 2018

Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00264.X

21 January 2018

Smoking cessation rapidly increases circulating progenitor cells in peripheral blood in chronic smokers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00264.X

21 January 2018

HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00264.X

21 January 2018

Ex vivo pretreatment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00264.X

21 January 2018

Endothelial progenitor cells: characterization and role in vascular biology

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00264.X

21 January 2018

Serum level of advanced glycation end-products (AGEs) is an independent determinant of plasminogen activator inhibitor-1 (PAI-1) in nondiabetic general population

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00264.X

21 January 2018

Circulating advanced glycation end products (AGEs) and soluble form of receptor for AGEs (sRAGE) are independent determinants of serum monocyte chemoattractant protein-1 (MCP-1) levels in patients with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00264.X

21 January 2018

Risk factors for coronary artery disease, circulating endothelial progenitor cells, and the role of HMG-CoA reductase inhibitors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00264.X

21 January 2018

High-density lipoprotein exerts vasculoprotection via endothelial progenitor cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00264.X

21 January 2018

Positive association of circulating levels of advanced glycation end products (AGEs) with pigment epithelium-derived factor (PEDF) in a general population.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00264.X

21 January 2018

Possible involvement of advanced glycation end-products (AGEs) in the pathogenesis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00264.X

21 January 2018

Advanced glycation end products depress function of endothelial progenitor cells via p38 and ERK 1/2 mitogen-activated protein kinase pathways

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00264.X

21 January 2018

Rosiglitazone via upregulation of Akt/eNOS pathways attenuates dysfunction of endothelial progenitor cells, induced by advanced glycation end products

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00264.X

21 January 2018

Identifiers

10.1111/J.1755-5922.2011.00264.X

1 reference

Europe PubMed Central

14 September 2017

1 reference

Europe PubMed Central

14 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39711731&oldid=2089081210"